These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. MicroRNA in colorectal cancer: from benchtop to bedside. Wu WK; Law PT; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ Carcinogenesis; 2011 Mar; 32(3):247-53. PubMed ID: 21081475 [TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in colorectal cancer. Liu M; Chen H J Genet Genomics; 2010 Jun; 37(6):347-58. PubMed ID: 20621017 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in cancer management and their modulation by dietary agents. Karius T; Schnekenburger M; Dicato M; Diederich M Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs, ultraconserved genes and colorectal cancers. Rossi S; Kopetz S; Davuluri R; Hamilton SR; Calin GA Int J Biochem Cell Biol; 2010 Aug; 42(8):1291-7. PubMed ID: 19497386 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Hummel R; Hussey DJ; Haier J Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396 [TBL] [Abstract][Full Text] [Related]
10. MiRNAs as biomarkers and therapeutic targets in cancer. Heneghan HM; Miller N; Kerin MJ Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466 [TBL] [Abstract][Full Text] [Related]
11. Implications of the histological determination of microRNAs in the screening, diagnosis and prognosis of colorectal cancer. Menéndez P; Villarejo P; Padilla D; Menéndez JM; Rodríguez-Montes JA J Surg Oncol; 2013 Jul; 108(1):70-3. PubMed ID: 23609475 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs. Nana-Sinkam SP; Croce CM IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of serum microRNAs in colorectal cancer. Menéndez P; Villarejo P; Padilla D; Menéndez JM; Montes JA J Surg Oncol; 2013 Feb; 107(2):217-20. PubMed ID: 22903548 [TBL] [Abstract][Full Text] [Related]
14. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Song B; Ju J Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990 [TBL] [Abstract][Full Text] [Related]
15. [MicroRNAs: novel biomarkers for human cancer]. Bartels CL; Tsongalis GJ Ann Biol Clin (Paris); 2010; 68(3):263-72. PubMed ID: 20478768 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies. Wei J; Xie L; Taron M; Rosell R; Liu B Drug News Perspect; 2010 Dec; 23(10):655-61. PubMed ID: 21180651 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of microRNAs in prostate cancer: implications for personalized medicine. Gandellini P; Folini M; Zaffaroni N Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and cancer--new paradigms in molecular oncology. Negrini M; Nicoloso MS; Calin GA Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171 [TBL] [Abstract][Full Text] [Related]
19. Systemic microRNAs: novel biomarkers for colorectal and other cancers? Heneghan HM; Miller N; Kerin MJ Gut; 2010 Jul; 59(7):1002-4; author reply 1004. PubMed ID: 20581247 [No Abstract] [Full Text] [Related]
20. miRNAs as molecular biomarkers of cancer. Fabbri M Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]